Emergency Contraception with Levonorgestrel: A Trusted Solution
| Product dosage: 15mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.02 (0%) | 🛒 Add to cart |
| 90 | $0.72 | $73.53 $64.50 (12%) | 🛒 Add to cart |
| 120 | $0.67 | $98.04 $79.98 (18%) | 🛒 Add to cart |
| 180 | $0.62 | $147.06 $110.94 (25%) | 🛒 Add to cart |
| 240 | $0.59 | $196.08 $142.76 (27%) | 🛒 Add to cart |
| 360 | $0.57
Best per pill | $294.12 $205.54 (30%) | 🛒 Add to cart |
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.75 | $44.72 (0%) | 🛒 Add to cart |
| 90 | $0.66 | $67.08 $59.34 (12%) | 🛒 Add to cart |
| 120 | $0.62 | $89.44 $73.96 (17%) | 🛒 Add to cart |
| 180 | $0.56 | $134.16 $101.48 (24%) | 🛒 Add to cart |
| 270 | $0.54 | $201.24 $145.34 (28%) | 🛒 Add to cart |
| 360 | $0.52
Best per pill | $268.32 $186.62 (30%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Emergency contraception is a critical component of reproductive healthcare, offering a reliable option for preventing unintended pregnancy after unprotected intercourse or contraceptive failure. The i pill, containing the well-established progestin levonorgestrel, provides a scientifically validated method to reduce this risk when used appropriately. This product is designed for timely intervention, leveraging hormonal mechanisms that have been extensively studied and deemed safe for use. It represents an essential backup option, empowering individuals with greater control over their reproductive outcomes through prompt action.
Features
- Contains 1.5 mg levonorgestrel as the active ingredient
- Single-dose tablet formulation for convenience
- Works primarily by inhibiting or delaying ovulation
- Does not disrupt an established pregnancy
- Available without prescription in many regions
- Manufactured under strict pharmaceutical quality standards
Benefits
- Effectively reduces the risk of pregnancy when taken within 72 hours after unprotected intercourse
- Provides a discreet and private option for emergency contraception
- Offers peace of mind in situations of contraceptive failure or unprotected sex
- Does not require ongoing administration like regular birth control methods
- Supported by decades of clinical research demonstrating safety and efficacy
- Accessible without a prescription in numerous countries, facilitating timely use
Common use
This medication is specifically indicated for emergency contraception following unprotected sexual intercourse or known or suspected contraceptive failure (such as condom breakage, missed combined oral contraceptive pills, or dislodged diaphragms). It is intended for occasional use rather than as a regular contraceptive method. The product is most effective when taken as soon as possible after unprotected intercourse, with efficacy declining as the interval between intercourse and administration increases.
Dosage and direction
The recommended dosage consists of a single 1.5 mg levonorgestrel tablet taken orally as soon as possible after unprotected intercourse, preferably within 72 hours. While the medication remains somewhat effective up to 120 hours (5 days) after intercourse, efficacy decreases significantly with time. The tablet may be taken with or without food. If vomiting occurs within 3 hours of administration, a repeat dose should be taken. No additional doses are required for multiple acts of unprotected intercourse within the same menstrual cycle, though consultation with a healthcare provider is advised in such situations.
Precautions
This medication is not intended for routine use as a primary contraceptive method. It does not protect against sexually transmitted infections, including HIV/AIDS. Women with known hypersensitivity to levonorgestrel or any component of the formulation should avoid this product. While generally well-tolerated, individuals with severe hepatic impairment should use with caution. The medication may be less effective in women with higher body mass index (BMI), particularly those with BMI > 30 kg/m². It does not terminate an existing pregnancy and will not affect a developing embryo if implantation has already occurred.
Contraindications
This product is contraindicated in cases of known or suspected pregnancy, as it is not effective for termination and provides no therapeutic benefit in this context. Additionally, it should not be used by individuals with hypersensitivity to levonorgestrel or any excipients in the formulation. Those with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should avoid this product due to the presence of lactose. There are no absolute age restrictions, though younger patients should ensure appropriate understanding of proper use.
Possible side effects
The most commonly reported adverse reactions include nausea (reported in approximately 15-20% of users) and vomiting (approximately 4-6% of users). Other frequently observed effects include fatigue, headache, dizziness, breast tenderness, lower abdominal pain, and irregular menstrual bleeding. These symptoms are generally mild and self-limiting, typically resolving within 24-48 hours without intervention. Some women may experience alterations in their menstrual cycle, including earlier or later onset of menses, and changes in flow characteristics. These menstrual changes usually resolve by the next cycle.
Drug interaction
Levonorgestrel metabolism may be induced by drugs such as barbiturates, bosentan, carbamazepine, felbamate, griseofulvin, oxcarbazepine, phenytoin, rifampicin, St. John’s wort, topiramate, and certain HIV medications. These substances may potentially decrease levonorgestrel concentrations and reduce efficacy. Conversely, drugs that inhibit cytochrome P450 3A4 enzymes might increase levonorgestrel levels, though clinical significance remains uncertain. While not extensively documented, concomitant use with other hormonal contraceptives or hormone therapies may potentially affect efficacy of either product.
Missed dose
As this medication is administered as a single dose for emergency contraception, the concept of a “missed dose” does not apply in the conventional sense. However, if vomiting occurs within 3 hours of administration, a repeat dose should be taken immediately. If a woman has unprotected intercourse after taking the medication, the tablet will not provide protection for subsequent acts of intercourse. For ongoing contraceptive needs, alternative methods should be implemented following emergency contraception use.
Overdose
There have been no reports of serious adverse consequences from levonorgestrel overdose. Given the single-dose nature of this product and the relatively high safety margin of progestins, significant toxicity is unlikely. Possible effects might include nausea, vomiting, and drowsiness. No specific antidote exists, and treatment should be symptomatic and supportive. Medical attention should be sought if concerning symptoms develop or if very large quantities have been ingested, particularly in pediatric cases.
Storage
Store at room temperature (15-30°C or 59-86°F) in the original packaging to protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. The tablet should not be stored in bathrooms or other areas with high humidity, as moisture may compromise the integrity of the formulation.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual responses to medication may vary. This product is not intended to replace consultation with a qualified healthcare professional. Users should read the package insert carefully and consult with a physician or pharmacist regarding their specific situation, especially if they have underlying medical conditions or are taking other medications. The manufacturer is not liable for incorrect use or individual variations in response.
Reviews
Clinical studies involving thousands of women have demonstrated that levonorgestrel emergency contraception reduces the risk of pregnancy by 60-90% when taken within 72 hours of unprotected intercourse. The World Health Organization has included levonorgestrel emergency contraception on its List of Essential Medicines, affirming its importance in reproductive healthcare. Post-marketing surveillance data from multiple countries supports the favorable safety profile of this product, with most adverse events being mild and self-limiting. Healthcare professionals generally regard it as a valuable option for preventing unintended pregnancy when used appropriately according to established guidelines.